Similar articles for PMID: 32737246

Year	Number of Results
1996	2
1999	1
2001	1
2002	1
2007	1
2008	3
2009	1
2010	8
2011	8
2012	6
2013	12
2014	9
2015	7
2016	10
2017	8
2018	16
2019	9
2020	13
2021	16
2022	7
2023	7
2024	1

1

Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion.

Chodyla M, Demircioglu A, Schaarschmidt BM, Bertram S, Bruckmann NM, Haferkamp J, Li Y, Bauer S, Podleska L, Rischpler C, Forsting M, Herrmann K, Umutlu L, Grueneisen J. Chodyla M, et al. J Nucl Med. 2021 Mar;62(3):348-353. doi: 10.2967/jnumed.120.248260. Epub 2020 Jul 31. J Nucl Med. 2021. PMID: 32737246 Free article. Clinical Trial.

2

¹⁸F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas.

Grueneisen J, Schaarschmidt B, Demircioglu A, Chodyla M, Martin O, Bertram S, Wetter A, Bauer S, Fendler WP, Podleska L, Forsting M, Herrmann K, Umutlu L. Grueneisen J, et al. J Nucl Med. 2019 Nov;60(11):1537-1542. doi: 10.2967/jnumed.119.226761. Epub 2019 Mar 29. J Nucl Med. 2019. PMID: 30926647 Free article.

3

Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.

Schwenzer NF, Schmidt H, Gatidis S, Brendle C, Müller M, Königsrainer I, Claussen CD, Pfannenberg AC, Schraml C. Schwenzer NF, et al. J Magn Reson Imaging. 2014 Nov;40(5):1121-8. doi: 10.1002/jmri.24497. Epub 2013 Nov 8. J Magn Reson Imaging. 2014. PMID: 24923481

4

Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.

Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, Glielmi C, Friedman KP. Rakheja R, et al. AJR Am J Roentgenol. 2013 Nov;201(5):1115-9. doi: 10.2214/AJR.13.11304. AJR Am J Roentgenol. 2013. PMID: 24147485

5

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

Goense L, Heethuis SE, van Rossum PSN, Voncken FEM, Lagendijk JJW, Lam MGEH, Terhaard CH, van Hillegersberg R, Ruurda JP, Mook S, van Lier ALHMW, Lin SH, Meijer GJ. Goense L, et al. Nucl Med Commun. 2018 Jan;39(1):60-67. doi: 10.1097/MNM.0000000000000771. Nucl Med Commun. 2018. PMID: 29023336

6

Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.

Andreou D, Boldt H, Pink D, Jobke B, Werner M, Schuler M, Reichardt P, Tunn PU. Andreou D, et al. Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1076-83. doi: 10.1007/s00259-013-2680-8. Epub 2014 Feb 12. Eur J Nucl Med Mol Imaging. 2014. PMID: 24519553 Clinical Trial.

7

Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.

Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Mechtersheimer G, Schmitt T, Lehner B, Haberkorn U, Stroebel P, Kasper B. Dimitrakopoulou-Strauss A, et al. J Nucl Med. 2010 Apr;51(4):551-8. doi: 10.2967/jnumed.109.070862. J Nucl Med. 2010. PMID: 20351350 Free article. Clinical Trial.

8

Parameters of simultaneous 18F-FDG-PET/MRI predict tumor stage and several histopathological features in uterine cervical cancer.

Surov A, Meyer HJ, Schob S, Höhn AK, Bremicker K, Exner M, Stumpp P, Purz S. Surov A, et al. Oncotarget. 2017 Apr 25;8(17):28285-28296. doi: 10.18632/oncotarget.16043. Oncotarget. 2017. PMID: 28423698 Free PMC article.

9

Comparison of 3T diffusion-weighted MRI and ¹⁸F-FDG PET/CT in musculoskeletal tumours: quantitative analysis of apparent diffusion coefficients and standardized uptake values.

Lee SY, Jee WH, Yoo IR, Jung JY, Im SA, Chung YG, Kang JH. Lee SY, et al. Br J Radiol. 2019 Oct;92(1102):20181051. doi: 10.1259/bjr.20181051. Epub 2019 Jul 24. Br J Radiol. 2019. PMID: 31322913 Free PMC article.

10

Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.

Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC. Evilevitch V, et al. Clin Cancer Res. 2008 Feb 1;14(3):715-20. doi: 10.1158/1078-0432.CCR-07-1762. Clin Cancer Res. 2008. PMID: 18245531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year